Drug establishmentActive, Registered FY2026FDA warning letter on file

ImmunityBio, Inc.

ImmunityBio, Inc. is an FDA-registered drug establishment (FEI 3020068662) located in San�Diego, California. The facility is active, registered for FY2026. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Mar 13, 2026
False & Misleading Claims/Misbranded

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number
3020068662
Address
3530 John�Hopkins�Ct., San�Diego, California
Establishment type
Drug establishment
Products / operations
Analytical testing
Registration status
Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file
None on file
Form 483 observations
None on file

FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.

Questions

Is ImmunityBio, Inc. registered with the FDA?

Yes. ImmunityBio, Inc. is an FDA-registered drug establishment (FEI 3020068662) in San�Diego, California. Its current registration status is Active, Registered FY2026.

Has ImmunityBio, Inc. received an FDA warning letter?

Yes. FDA issued a warning letter to ImmunityBio, Inc.; the most recent is dated Mar 13, 2026 (False & Misleading Claims/Misbranded).

What does ImmunityBio, Inc. do?

ImmunityBio, Inc.'s FDA-registered operations are: Analytical testing.

Related facilities

Source: FDA public data · status as of 2026-06-06

The Quality Brief

Every new FDA drug and device warning letter and recall, summarized once a week. Free.